Failure of combination therapy with lamivudine and famciclovir following lamivudine monotherapy for hepatitis B virus infection in patients coinfected with human immunodeficiency virus-1.

Abstract

Individuals coinfected with human immunodeficiency virus 1 (HIV-1) and hepatitis B virus (HBV) often receive treatment with an antiretroviral regimen including lamivudine. Lamivudine monotherapy for HBV may lead to drug-resistant mutations in a significant number of patients. The virological and biochemical responses of 8 patients coinfected with HBV/HIV-1… (More)

Topics

Cite this paper

@article{Matthews2001FailureOC, title={Failure of combination therapy with lamivudine and famciclovir following lamivudine monotherapy for hepatitis B virus infection in patients coinfected with human immunodeficiency virus-1.}, author={Garrett Matthews and D. Pillay and Peter F Cane and David Ratcliffe and Brian George Gazzard and M. Nelson}, journal={Clinical infectious diseases : an official publication of the Infectious Diseases Society of America}, year={2001}, volume={33 12}, pages={2049-54} }